top of page

Featured in CNBC: Japanese yen and Swiss franc top hedges against Trump tariffs, according to analysts

  • Ebrahim Rahbari
  • Apr 7
  • 2 min read

Updated: Apr 8

Key Points

  • “The Japanese yen will be a good — and probably the best — candidate to hide from trade tensions and a U.S. recession,” said Ebrahim Rahbari, head of rates strategy at Absolute Strategy Research.

  • A more interesting question is whether there could be more “exotic” hedges aside from the classic safe havens, said Rahbari, who named the Brazilian real as an option.


Investors are flocking to safe haven assets after U.S. President Donald Trump announced a swathe of reciprocal tariffs last week — and some are looking at the Japanese yen, bonds, as well as a few other “exotic” assets.


“The Japanese yen will be a good — and probably the best — candidate to hide from trade tensions and a U.S. recession, for a whole host of familiar reasons,” said Ebrahim Rahbari, head of rates strategy at Absolute Strategy Research.


“It is cheap, the likely decline in U.S. interest rates will narrow the rate differentials to the yen, and even though Japan is a prominent exporter, its overall reliance on trade is lower now, particularly as fiscal policy has been loose,” he told CNBC via email.


The yen has strengthened around 3% against the greenback since April 2, according to data from LSEG. Rahbari added that the Swiss franc is another “obvious candidate” as an investment hedge. The franc has likewise appreciated more than 3% to 0.846 against the U.S. dollar — a fresh six-month high.

Those moves come as other currencies around the world weaken.


A more interesting question is whether there could be more “exotic” hedges aside from the classic safe havens, said Rahbari, who named the Brazilian real as an option.


“The idea being that it is cheap, has high carry and that it is relatively less exposed to global trade,” said Rahbari, adding that the real has been one of the major outperformers in currencies this year.


Comments


Contact Us

Register for a trial. Speak to our team about our research and products. Provide feedback on the service.
We would love to hear from you.

Are you an institutional investor?

Get in touch

London: +44 (0)20 7073 0730

Connecticut: +1 917 678 1328

Melbourne: + 61 3 9691 5438 

  • LinkedIn
  • X
bottom of page